CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYOE), the developer of a suite of cost-effective cervical cell collection devices for the early detection of cancer and sexually transmitted diseases, today reported good progress during its first quarter ended March 31, 2008.
